![]() |
Volumn 62, Issue 4, 2006, Pages 502-503
|
After the London tragedy, is it still possible to consider Phase I is safe? [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
ACUTE LEUKEMIA;
AGING;
AGRANULOCYTOSIS;
ANXIETY;
CENTRAL RETINA ARTERY OCCLUSION;
CLINICAL PHARMACOLOGY;
CLINICAL PRACTICE;
CONGENITAL MALFORMATION;
DISASTER;
DRUG ERUPTION;
DRUG FATALITY;
DRUG FEVER;
DRUG QUALITY;
DRUG RESEARCH;
DRUG SAFETY;
HEALTH SERVICE;
HEART ATRIUM FIBRILLATION;
HOSPITALIZATION;
HUMAN;
INCIDENTAL FINDING;
LETTER;
LUNG CANCER;
MORTALITY;
PERITONITIS;
PHYSICAL DISABILITY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REGISTER;
RISK ASSESSMENT;
SEX DIFFERENCE;
TRAFFIC ACCIDENT;
UNSTABLE ANGINA PECTORIS;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE I AS TOPIC;
HUMANS;
IMMUNOLOGIC FACTORS;
RISK ASSESSMENT;
|
EID: 33748756586
PISSN: 03065251
EISSN: 13652125
Source Type: Journal
DOI: 10.1111/j.1365-2125.2006.02740.x Document Type: Letter |
Times cited : (32)
|
References (7)
|